Snowball logo
logo
6006

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A

600613 • SHG
¥8.25¥0.00  (0%)
Estimate
P/E
165
EPS
0.05
Beta
0.563
Growth
Revenue, YoY
-11.59%
Net income, YoY
-49.02%
FCF, YoY
-21.59%
About the company
Ticker
600613
ISIN
CNE000000453
Country
China
Sector (GICS)
Healthcare
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate vitamin B6 injection, sodium cantharidin injection, loquat cough granules, strong loquat dew, loquat cough capsules, jinwu gutong capsules, coral ringworm net, jingwu capsules, quantianma capsules, yindan xintai pills, etc. The company was founded in 1990 and is based in Shanghai, China.

Frequently asked questions

What sector does Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) operate in?

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.

What is Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) current stock price?

As of the latest data, Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A stock price is CN¥8.25, with a previous close of CN¥8.25.

What is Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) current market capitalization?

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A market cap is approximately 3.95 billion.

What is Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.05.

What is Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) Price-to-Earnings (P/E) ratio?

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A current P/E ratio is 165.

Does Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) pay dividends?

No. Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A does not pay a dividend.

What is Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) beta (volatility) score?

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A has a beta of 0.563, indicating lower volatility than the overall market.